... development, and polydipsia. 11 (57.9%) patients had obesity, and three of our patients were diagnosed with metabolic syndrome in late adolescence or early adulthood. Three of our cases diagnosed with growth hormone deficiency received growth hormone therapy, which exerted positive effects on growth promotion...

... treatment option. However, our understanding of predictors of survival after surgery remains incomplete. The aim of the study was to evaluate metabolic syndrome (MetS) as a prognostic factor in pNET. Methods: In a retrospective single-center cohort study, we examined the influence of MetS in 120 patients...

... of corticosteroids is reserved for the glucocorticoid receptor (GR). Here, we assessed the relationship of glucocorticoid sensitivity-altering GR polymorphisms with anthropometrics and metabolic syndrome (MetS) in corticosteroid users. Methods: In this population-based cohort study (Lifelines), we genotyped 10,621...

...Daniel P. Cardinali; Rüdiger Hardeland The metabolic syndrome (MS) is a collection of risk factors for cardiovascular disease, including obesity, hypertension, hyperinsulinemia, glucose intolerance and dyslipidemia. MS is associated with low-grade inflammation of the white adipose tissue, which can...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prolactin Testosterone deficiency Metabolic parameters Cabergoline Testosterone replacement Hyperprolactinemia Metabolic syndrome Insulin resistance Pituitary tumors...

... in the pathogenesis of obesity and glucose intolerance and is reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of 12- and 60-month treatment with cabergoline (CAB) on metabolic syndrome (MetS) in patients with prolactinomas. Patients and Methods: 61...

...Elizabeth K. Nousen; Juliana G. Franco; Elinor L. Sullivan The increased prevalence and high comorbidity of metabolic syndrome (MetS) and mental health disorders (MHDs) have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between MetS and MHDs...

...Daniel P. Cardinali; Pilar Cano; Vanesa Jiménez-Ortega; Ana I. Esquifino Metabolic syndrome (MS) patients exhibit sleep/wake disturbances and other circadian abnormalities, and these may be associated with more rapid weight increase and development of diabetes and atherosclerotic disease...

...Philippe Chanson; Sylvie Salenave Although the concept of metabolic syndrome (MetS) as a disease entity continues to be debated, it provides a means by which patients at risk for diabetes and cardiovascular disease can be identified and categorized with routinely available criteria. Insulin...

... is mainly due to metabolic complications, such as metabolic syndrome, but also to vascular and cardiac alterations such as atherosclerosis and cardiac structural and functional changes. In the clinical management of patients with CS the focus should be on identifying the global cardiovascular risk...

...</italic> GPR-54 Diabetes Metabolic syndrome Hypogonadism Testosterone Over the past few decades, obesity has become a global health challenge. Between 1980 and 2004 the prevalence of obesity increased from 15 to 33% in the United States – a pattern mirrored across the world [ 1...